HIT! High Impact Clinical Trials 2 - New Insights Into Ongoing Trials

29 Mar 2026 9:25 a.m. 10:55 a.m.
Main Hall
AdeeraLevin Moderator Canada
Andrea Viecelli Moderator Switzerland
RobertoPecoits-Filho Moderator United States

Time Session
9:25 a.m.
9:37 a.m.
RESOLVE Trial: Sodium Concentration in Dialysis Populations — a Global Cluster Randomized Study
MegJardine Speaker meg.jardine@sydney.edu.auAustralia
9:37 a.m.
9:40 a.m.
Q&A
9:40 a.m.
9:52 a.m.
Key Aspects of the VOICE Clinical Trial on Anemia in Dialysis Patients
ShuchiAnand Speaker sanand2@stanford.eduUnited States
9:52 a.m.
9:55 a.m.
Q&A
9:55 a.m.
10:07 a.m.
TEACH-PD Cluster Randomized Controlled Trial: Targeted Education ApproaCH to improve Peritoneal Dialysis Outcomes
JosephineChow Speaker Josephine.Chow@health.nsw.gov.auAustralia
10:07 a.m.
10:10 a.m.
Q&A
10:10 a.m.
10:22 a.m.
The Renal Life Cycle: Development, Maturity, and Decline
HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
10:22 a.m.
10:25 a.m.
Q&A
10:25 a.m.
10:37 a.m.
Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-proven Primary Glomerular Diseases: Multi-center, Multi-arm and Multi-stage- the Story So Far
Joint Presentation
Selvin Sundar RajMani Speaker selvinsr@gmail.comIndia
SuceenaAlexander Speaker suceena@gmail.comIndia
10:37 a.m.
10:40 a.m.
Q&A
10:40 a.m.
10:52 a.m.
ASPIRE Trial: Aspirin Use in Dialysis Patients in China
XueqingYU Speaker yuxueqing@gdph.org.cnChina
10:52 a.m.
10:55 a.m.
Q&A